« Return to News | CROs/Service Providers

Marken launches new website and marketing campaign

Friday, September 30, 2011 12:01 PM

Marken has launched a new global brand and advertising campaign to reflect the unique position that it holds in the pharmaceutical industry.  The campaign will be introduced globally with the launch of its new website and will include its new brand and tagline: "Global Life Science Supply Chain Solutions.”

"The Marken name has been synonymous with reliability and impeccable customer service," said Wes Wheeler, Marken's chief executive officer. "This new branding and marketing campaign reflect the voice of our clients who trust Marken to provide supply chain solutions to the clinical and commercial segments of the pharmaceutical industry. This is especially relevant as we bring more pharmaceutical depots online according to our master plan."

Marken's new purpose-built depots will form a 'Pharmaceutical Services Network' which will support the conduct of clinical trials in remote locations. Each depot will be able to store and distribute clinical trial supplies, aggregate and store frozen research specimens for batch shipment to central laboratories and to provide secure GMP compliant facilities to support more than 6000 investigator sites in over 100 countries.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.